Literature DB >> 8005797

Effect of carbon monoxide breathing on hypoxia and radiation response in the SCCVII tumor in vivo.

C Grau1, M Nordsmark, A A Khalil, M R Horsman, J Overgaard.   

Abstract

PURPOSE: To study the influence of a clinically relevant concentration of carbon monoxide (CO) on tumor oxygenation and response to irradiation. METHODS AND MATERIALS: The murine tumor model was the SCCVII squamous cell carcinoma transplanted to the feet of C3H/Km mice.
RESULTS: Sixty minutes of breathing CO at 200 ppm resulted in a carboxyhemoglobin level of 15%. This resulted in a reduction in p50 (the oxygen partial pressure at which hemoglobin is 50% saturated) to 78% of the control value, and a decrease in tumor blood perfusion to 73% of the control value. The combined effect of a decrease in effective hemoglobin and blood perfusion resulted in a reduction in tumor oxygen supply to 62% of the control value. In agreement with this, intratumoral pO2 measurements showed a significant increase in tumor hypoxia, such that the percentage of measurements with low pO2 (< or = 5 mmHg) increased from 33% to 62%. The fraction of clonogenic hypoxic cells, measured radiobiologically by paired cell survival curves, similarly increased from 0.2% to 3.8%. Radiation sensitivity, evaluated from in vivo-in vitro excision assay, was significantly decreased by CO breathing with both single dose and fractionated irradiation. The observed enhancement ratios for radiation given in 1, 4, 8, and 12 fractions were 0.71, 0.77, 0.83, and 0.71, respectively.
CONCLUSION: The present SCCVII tumor data confirm the general experimental observation that CO breathing significantly increases tumor hypoxia and reduces the effectiveness of ionizing irradiation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8005797     DOI: 10.1016/0360-3016(94)90436-7

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  Response of hepatoma 9618a and normal liver to host carbogen and carbon monoxide breathing.

Authors:  S P Robinson; L M Rodrigues; J R Griffiths; M Stubbs
Journal:  Neoplasia       Date:  1999-12       Impact factor: 5.715

2.  Pretreatment anemia and survival in nasopharyngeal carcinoma.

Authors:  Lu-Ning Zhang; Jie Tang; Xiao-Wen Lan; Pu-Yun OuYang; Fang-Yun Xie
Journal:  Tumour Biol       Date:  2015-09-10

3.  Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck Cancer.

Authors:  Sana D Karam; Krishna Reddy; Patrick J Blatchford; Tim Waxweiler; Alicia M DeLouize; Ayman Oweida; Hilary Somerset; Carrie Marshall; Christian Young; Kurtis D Davies; Madeleine Kane; Aik Choo Tan; Xiao Jing Wang; Antonio Jimeno; Dara L Aisner; Daniel W Bowles; David Raben
Journal:  Clin Cancer Res       Date:  2018-07-03       Impact factor: 12.531

4.  Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer.

Authors:  Maura L Gillison; Qiang Zhang; Richard Jordan; Weihong Xiao; William H Westra; Andy Trotti; Sharon Spencer; Jonathan Harris; Christine H Chung; K Kian Ang
Journal:  J Clin Oncol       Date:  2012-05-07       Impact factor: 44.544

5.  Detection of hypoxic cells in a C3H mouse mammary carcinoma using the comet assay.

Authors:  P L Olive; M R Horsman; C Grau; J Overgaard
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  Cigarette smoking complements the prognostic value of baseline plasma Epstein-Barr virus deoxyribonucleic acid in patients with nasopharyngeal carcinoma undergoing intensity-modulated radiation therapy: a large-scale retrospective cohort study.

Authors:  Jia-Wei Lv; Yu-Pei Chen; Guan-Qun Zhou; Ling-Long Tang; Yan-Ping Mao; Wen-Fei Li; Rui Guo; Ai-Hua Lin; Jun Ma; Ying Sun
Journal:  Oncotarget       Date:  2016-03-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.